Digestive System Adenocarcinoma — Trials

Digestive System Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

5,072 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,374
Recruiting: 799
Ph III recruiting: 82
Growth YoY: +12.1%
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (619)

clinicaltrialsPublishedShowing 651–700 of 1,007 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07103668	A Phase III Randomized Study in CLDN18.2-positive Unresectable Locally Advanced Gastric Cancer Patients	recruiting	Phase 3	150	Suzhou Immunofoco Biotechnology Co., LtdINDUSTRY	1	Oct 23, 2025	clinicaltrials
NCT03551951	Tumor Cell and DNA Detection in the Blood, Urine, and Bone Marrow	recruiting	—	320	University of Missouri-ColumbiaOTHER	1	Oct 8, 2025	clinicaltrials